Skip to main content
. Author manuscript; available in PMC: 2020 Feb 24.
Published in final edited form as: Lancet Haematol. 2019 Jun 14;6(8):e419–e428. doi: 10.1016/S2352-3026(19)30104-8

Table 1:

Baseline characteristics

Original Expansion Total
N=35 N=50 N=85
Median age (IQR), years 55 (9.5) 54 (7) 55 (8)
Men, n (%) 25 (71) 31 (62) 56 (65·9)
Women 10 (29) 19 (38) 29 (34·1)
ECOG performance status, n (%)
0 23 (66) 27 (54) 50 (58·8)
1 12 (34) 23 (46) 35 (41·2)
Rai stage, n (%)
0 1 (2·9) 0 (0) 1 (1·2)
1 6 (17·1) 14 (28) 20 (23·5)
2 8 (22·9) 13 (26) 21 (24·7)
3 4 (11·4) 7 (14) 11 (12·9)
4 16 (45·7) 13 (26) 29 (34·1)
Median WBC (IQR), × 109/L 78 (146·7) 115 (136·7) 109 (146·5)
Median haemoglobin (IQR), g/dL 12 (3·2) 11 (3·3) 12 (3·3)
Median haematocrit (IQR), % 37 (9·6) 35 (9·2) 37 (9·7)
Median platelets (IQR), × 109/L 141 (92) 127 (74) 127 (79)
Median BM involvement (IQR), % 47 (37·5) 77 (31·3) 60 (40)
Median IgG (IQR), mg/dL 753 (481) 631 (425) 676 (463·3)
Median IgA (IQR), mg/dL 74 (52·8) 79 (47) 77 (53·5)
Median β2-microglobulin (IQR), mg/L 4 (1·9) 2 (1·9) 3·0 (2·2)
IGHV unmutated 21/32 (65·6) 25/47 (53·2) 46/79 (58·2%)
ZAP-70 positive 21/33 (63·6) 22/43 (51·1) 43/76 (56·6%)
del(17p) 4/33 (12·1) 0/50 (0) 4/83 (4·8%)
del(11q) 9/33 (27·3) 8/50 (16) 17/83 (20·5%)
del(13q) 17/33 (51·5) 28/50 (56) 45/83 (54·2%)
Normal FISH 5/33 (15·2) 9/50 (18) 14/82 (17·1%)
Trisomy 12 6/33 (18·2) 8/50 (16) 14/83 (16·9%)
6q detected 1/33 (3·0) 1/50 (2) 2/82 (2·4%)
Complex cytogenetics 14/83 (16·9%)
Including del(17p) 3/33 (9·1) 1/50 (2) 4/83 (4·8%)
Without del(17p) 4/33 (12·1) 6/50 (12) 10/83 (12·1%)
TP53 mutation 2/33 (6·1) 1/48(2·1) 3/81 (3·7%)
NOTCH1 mutation 2/27 (7·4) 3/31 (9·7) 5/58 (8·6%)

BM=bone marrow. ECOG=Eastern Cooperative Oncology Group. FISH=fluorescence in situ hybridisation, non-hierarchical. Ig=immunoglobulin. IGHV=immunoglobulin heavy-chain variable region. WBC=white blood cell.